Maxcyte (MXCT) Change in Inventory (2020 - 2026)
Maxcyte's (MXCT) quarterly Change in Inventory came in at $380000.0 in Q1 2026, up 171.56% year-on-year from $139930.7 in Q1 2025, and up 427.78% on a QoQ basis from $72000.0 in Q4 2025.
Maxcyte (MXCT) Change in Inventory (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Change in Inventory data on file, last reported at $380000.0 in Q1 2026.
- On a quarterly basis, Change in Inventory rose 171.56% year-over-year to $380000.0 in Q1 2026; TTM through Mar 2026 was $336000.0, a 119.49% increase from a year earlier, with the FY2025 full-year figure at -$575000.0, up 57.78% from the prior year.
- Change in Inventory for Q1 2026 stood at $380000.0, up from $72000.0 in the prior quarter.
- Over the last five years, Change in Inventory for MXCT reached as high as $1.7 million in Q1 2023 and fell as low as -$664000.0 in Q2 2024.
- Historically, Change in Inventory has averaged $380588.2 across 5 years, with a median of $241200.0 in 2022.
- Across the five-year window, Change in Inventory plunged 218.16% in 2024 and jumped 5450.0% in 2025, its largest moves.
- Year by year, Change in Inventory stood at $612300.0 in 2022, then fell by 27.16% to $446000.0 in 2023, then plunged by 218.16% to -$527000.0 in 2024, then soared by 113.66% to $72000.0 in 2025, then soared by 427.78% to $380000.0 in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $380000.0 in Q1 2026, $72000.0 in Q4 2025, and $107000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 65.20 Mn |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | 171.00 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -264.59 Mn |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | 380,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380,000.00 |
| Mar 31, 2026 | 380,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | -223,000.00 |
| Jun 30, 2025 | -223,000.00 |
| Mar 31, 2025 | -531,000.00 |
| Mar 31, 2025 | -531,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -664,000.00 |
| Jun 30, 2024 | -664,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Dec 31, 2023 | 446,000.00 |